Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Business Cocktail

Business Cocktail

Sep 20, 2017

Chinese pharma company Shanghai Fosun to acquire 74% stake in Indian company Gland Pharma for $1.09 billion

In July last year Chinese company Shanghai Fosun Pharmaceutical announced to acquire 74% per cent stake in Gland Pharma (Hyderabad-based Company) for not more than USD 1.09 billion. Initially the deal was set to acquire 86.08 per cent stake for USD 1.26 billion but it got revised as per the latest regulatory filing of the company.

Teva Pharmaceutical sell last of its Women’s Health Portfolio, gains another $2.48 billion

To progress repayment of term loan debt Teva Pharmaceutical has recently announced that  it has entered into two agreements to sell the remaining resources of its specialty global women’s health business for USD 1.38 billion. Earning from these sales, combined with earnings  from the recently announced sale of PARAGARD is around USD 2.48 billion.

Gates Foundation invests in Immunocore to fuel infectious disease R&D

Immunocore which is primarily known for its work in oncology is expanding its horizon into tuberculosis and HIV treatment. Bill & Melinda Gates Foundation is investing up to USD 40 million in Immunocore to fuel its research into the use of T cell receptor (TCR)-based therapeutics to effectively treat tuberculosis and HIV.

Disarm Therapeutics announces completion of Series A funding of USD 30 million

Disarm Therapeutics has recently announced completion of Series A funding of USD 30 million as it looks for a breakthrough approach in axonal degeneration. Funding is led by Atlas Venture and some co-investors like Lightstone Ventures and AbbVie Ventures.

Downloads

Article in PDF

Recent Articles
  1. Metastatic Prostate Cancer-Pipeline Insights, 2014
  2. Cholera vaccine delivered; Rice-inspired breakthroughs; International partnerships
  3. DelveInsight’s Oncology based Reports, 2015
  4. Vasomotor Symptoms of Menopause-Emerging Therapies
  5. On World AIDS Day…
pharma-news-for-applied-therapeutics-alnylam-rigel
Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Grants Fast Track for Lin BioScience’s LBS-007; Alnylam’s AMVUTTRA sNDA Under Review; FDA Approves RAPIBLYK for Atrial Fibrillation; Applied Therapeutics Receives CRL for Govorestat in Galactosemia; R289 Gets Fast Track for Lower-Risk MDS.

pharma-news-for-regeneron-astrazeneca-syndax
Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Approves PTC’s AADC Gene Therapy; DUPIXENT sBLA Acceptance for Urticaria; CHMP Recommends TAGRISSO for EGFR Lung Cancer; FDA Approves DANZITEN for CML; Syndax Wins FDA Approval for REVUFORJ in Acute Leukemia

Pharma-news-for-autolus-unicycive-abbvie
Notizia - Recent Pharma, Healthcare and Biotech Happenings

AUCATZYL Approved for R/R B-ALL; FDA Accepts NDA for Unicycive’s Oxylanthanum Carbonate; AstraZeneca and Amgen Report Positive Results in Chronic Rhinosinusitis; Nipocalimab Granted Breakthrough Designation for Sjögren’s Disease; AbbVie’s Schizophrenia Drug Fails Phase Studies

AbbVie Ventures
acquire
Atlas Venture
axonal degeneration
Business Cocktail
DelveInsight
Disarm Therapeutics
Gates Foundation
Gland Pharma
HIV
Immunocore
Lightstone Ventures
PARAGARD
Shanghai Fosun
Teva Pharmaceutical
Tuberculosis
loader